-- 
BioLineRx Jumps Most in Two Months After Trial Results

-- B y   G w e n   A c k e r m a n
-- 
2011-12-06T15:40:32Z

-- http://www.bloomberg.com/news/2011-12-06/biolinerx-jumps-most-in-two-months-after-trial-results-1-.html
BioLineRx Ltd. soared the most in two
months after saying that a trial of its neuropathic pain
molecule had “positive” results.  The shares jumped 5.5 percent, the biggest gain since Oct.
5, to 1.267 shekels at the 4:30 p.m. close in  Tel Aviv . The TA-
25 benchmark index declined 1.7 percent.  To contact the reporter on this story:
Gwen Ackerman in Jerusalem at 
 gackerman@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  